EDMONTON, Alberta, Aug. 8 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has added distributors of the VScan products in Macedonia, Bulgaria, Turkey, Serbia, Montenegro, Croatia, Bosnia, Herzegovina, Albania and Kosovo. It is anticipated based on market studies that these countries combined will purchase up to 1.5 million kits per year generating gross revenue of approximately $3.5 million US per year. The VScan kits generating the most interest for these areas are the VScan HIV and Tuberculosis (TB) kits.
Once again, the reason that the Company is able to increase its distribution network is the excellent test results that the kits get when tested by regulatory authorities. The VScan HIV test kits are ideal for these countries due to their accuracy using whole blood and the fact that they do not require refrigeration, medical facilities and trained medical personnel. They can be used with ease in remote areas. The VScan HIV test kit is the only test kit on the market to detect the antigen IgM. Detection of IgM can occur within 2 to 11 days of infection. Early detection is important in controlling the spread of HIV.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol “MSITF”. For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com .
NOTE: Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and filings with regulatory bodies.
Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,+1-780-430-6363
